Over the last 7 days, the Biotech industry has dropped 1.7%, driven by a pullback from CSL of 2.0%. In contrast, Immutep has gained 14%. In the past year, the industry has gained 15%. Looking forward, earnings are forecast to grow by 15% annually.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | AU$159.1b | AU$22.5b | AU$3.3b | 32x | 48x | 7.1x |
Sun, 23 Jun 2024 | AU$153.1b | AU$22.2b | AU$3.3b | 31.8x | 47x | 6.9x |
Tue, 21 May 2024 | AU$144.2b | AU$22.0b | AU$3.2b | 31x | 44.9x | 6.6x |
Thu, 18 Apr 2024 | AU$141.3b | AU$22.9b | AU$3.4b | 29.7x | 42x | 6.2x |
Sat, 16 Mar 2024 | AU$143.3b | AU$22.4b | AU$3.3b | 30.5x | 43.8x | 6.4x |
Mon, 12 Feb 2024 | AU$154.9b | AU$21.0b | AU$2.9b | 35x | 54.2x | 7.4x |
Wed, 10 Jan 2024 | AU$147.3b | AU$20.5b | AU$2.7b | 34.6x | 54.3x | 7.2x |
Fri, 08 Dec 2023 | AU$135.7b | AU$20.9b | AU$2.8b | 34.1x | 48.9x | 6.5x |
Sun, 05 Nov 2023 | AU$124.1b | AU$21.1b | AU$2.8b | 30x | 44.2x | 5.9x |
Tue, 03 Oct 2023 | AU$126.5b | AU$21.5b | AU$2.8b | 29.2x | 44.9x | 5.9x |
Thu, 31 Aug 2023 | AU$139.2b | AU$21.3b | AU$2.6b | 35.3x | 54x | 6.5x |
Sat, 29 Jul 2023 | AU$137.8b | AU$18.1b | AU$2.3b | 37.4x | 59x | 7.6x |
Mon, 26 Jun 2023 | AU$145.0b | AU$18.0b | AU$2.3b | 37.8x | 62.4x | 8.1x |
Wed, 24 May 2023 | AU$158.3b | AU$18.2b | AU$2.3b | 41x | 67.5x | 8.7x |
Fri, 21 Apr 2023 | AU$153.5b | AU$17.8b | AU$2.3b | 42x | 66.8x | 8.6x |
Sun, 19 Mar 2023 | AU$146.6b | AU$17.9b | AU$2.3b | 40.9x | 63.3x | 8.2x |
Tue, 14 Feb 2023 | AU$155.0b | AU$15.5b | AU$2.5b | 50.5x | 63x | 10x |
Thu, 12 Jan 2023 | AU$142.2b | AU$15.6b | AU$2.5b | 49x | 57.4x | 9.1x |
Sat, 10 Dec 2022 | AU$152.4b | AU$15.9b | AU$2.5b | 47.7x | 60.1x | 9.6x |
Mon, 07 Nov 2022 | AU$141.3b | AU$16.7b | AU$2.7b | 42.1x | 52.9x | 8.5x |
Wed, 05 Oct 2022 | AU$146.1b | AU$16.5b | AU$2.6b | 42.9x | 55.3x | 8.9x |
Fri, 02 Sep 2022 | AU$149.5b | AU$15.7b | AU$2.5b | 43.8x | 59.9x | 9.5x |
Sun, 31 Jul 2022 | AU$147.5b | AU$15.5b | AU$2.8b | 40.2x | 53x | 9.5x |
Tue, 28 Jun 2022 | AU$138.0b | AU$15.5b | AU$2.8b | 36.2x | 49.3x | 8.9x |
Thu, 26 May 2022 | AU$138.3b | AU$15.3b | AU$2.7b | 35.8x | 50.4x | 9.1x |
Sat, 23 Apr 2022 | AU$137.7b | AU$14.6b | AU$2.6b | 38.4x | 52.1x | 9.5x |
Mon, 21 Mar 2022 | AU$138.5b | AU$14.5b | AU$2.6b | 41.1x | 52.6x | 9.5x |
Wed, 16 Feb 2022 | AU$126.3b | AU$14.7b | AU$2.8b | 35.1x | 45.1x | 8.6x |
Fri, 14 Jan 2022 | AU$146.3b | AU$14.4b | AU$2.7b | 41.3x | 53.4x | 10.2x |
Sun, 12 Dec 2021 | AU$148.5b | AU$14.6b | AU$2.8b | 41x | 53.4x | 10.2x |
Tue, 09 Nov 2021 | AU$155.6b | AU$14.1b | AU$2.7b | 44.3x | 58.4x | 11x |
Thu, 07 Oct 2021 | AU$142.3b | AU$14.3b | AU$2.7b | 40.1x | 52.5x | 9.9x |
Sat, 04 Sep 2021 | AU$150.9b | AU$14.0b | AU$2.6b | 43.7x | 57.5x | 10.8x |
Mon, 02 Aug 2021 | AU$144.7b | AU$14.0b | AU$2.6b | 42.3x | 55.1x | 10.4x |
55.1x
How does Australian Biotech compare with similar industries?
AU Market | -2.20% | |
Healthcare | -1.08% | |
Biotech | -1.74% | |
Biotech | -1.74% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
IMM Immutep | AU$0.34 | 13.6% +AU$57.0m | 8.1% | PS121.4x | |
OPT Opthea | AU$0.41 | 7.9% +AU$36.9m | -29.3% | PS847.1x | |
TLX Telix Pharmaceuticals | AU$19.22 | 0.5% +AU$30.1m | 70.8% | PE203x | |
ARX Aroa Biosurgery | AU$0.63 | 5.9% +AU$12.0m | -30.8% | PS3.5x | |
TRP Tissue Repair | AU$0.43 | 72.0% +AU$10.9m | 53.6% | PS25.2x |